Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Abdul-Ghani

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Diabetes Care|April 29, 2011
Type 2 diabetes can be prevented with early pharmacological interventionRalph A DeFronzo, Muhammad Abdul-Ghani
The American Journal of Cardiology|August 2, 2011
Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucoseRalph A DeFronzo, Muhammad Abdul-Ghani
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretionMuhammad Abdul-Ghani, Ralph A DeFronzo
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
Diabetes Care|July 23, 2017
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes AlgorithmMuhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 26, 2021
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?Muhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 21, 2014
What are the pharmacotherapy options for treating prediabetes?Giuseppe Daniele, Muhammad Abdul-Ghani, Ralph A DeFronzo
Current Opinion in Clinical Nutrition and Metabolic Care|July 9, 2016
Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter?Muhammad Abdul-Ghani, Ralph A DeFronzo, Amin Jayyousi
The Lancet. Diabetes & Endocrinology|August 4, 2024
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetesMuhammad Abdul-Ghani, Pietro Maffei, Ralph Anthony DeFronzo
Diabetes, Obesity & Metabolism|June 17, 2026
How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic FutureMustafa Kanat, Muhammad Abdul-Ghani, Ralph A DeFronzo
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Diabetes Care|April 29, 2011
Type 2 diabetes can be prevented with early pharmacological interventionRalph A DeFronzo, Muhammad Abdul-Ghani
The American Journal of Cardiology|August 2, 2011
Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucoseRalph A DeFronzo, Muhammad Abdul-Ghani
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretionMuhammad Abdul-Ghani, Ralph A DeFronzo
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
Diabetes Care|July 23, 2017
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes AlgorithmMuhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 26, 2021
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?Muhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 21, 2014
What are the pharmacotherapy options for treating prediabetes?Giuseppe Daniele, Muhammad Abdul-Ghani, Ralph A DeFronzo
Current Opinion in Clinical Nutrition and Metabolic Care|July 9, 2016
Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter?Muhammad Abdul-Ghani, Ralph A DeFronzo, Amin Jayyousi
The Lancet. Diabetes & Endocrinology|August 4, 2024
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetesMuhammad Abdul-Ghani, Pietro Maffei, Ralph Anthony DeFronzo
Diabetes, Obesity & Metabolism|June 17, 2026
How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic FutureMustafa Kanat, Muhammad Abdul-Ghani, Ralph A DeFronzo
Pageof 10